Trade setup intelligence
Charts, patterns, liquidity, and profile weighting stay together before a setup is surfaced.
Signal through the silt.
Stocks, crypto and news catalysts, ranked into decisions
Follow market prices, charts and current catalysts without an account. When you need a decision workflow, move into ranked intelligence with data-quality checks and risk-aware review.
- Public markets
- Stocks · Crypto · NFTs
- Catalysts
- Source attributed
- Member intelligence
- Risk gated
Automated Market Intelligence
News Catalysts Mixed Directly with Stock Signals
News aggregation engine
Market-moving headlines are normalized, scored, and matched to the stocks they can move.
Automated controls
Automation is gated by data quality, risk limits, and explicit confidence thresholds.
Signal Workflow
Built Around the Decision Path
Ingest
Market headlines and bars enter one data-quality boundary.
Score
Catalysts are separated into bullish, neutral, and bearish context.
Rank
Opportunity boards blend catalyst impact with chart and risk signals.
Control
Execution-facing actions stay behind operator and risk checks.
Current Catalysts
Latest Market Headlines
Source-attributed headlines captured in the last hours, each linked to the public stock and crypto pages it mentions. Browse all market news
Century Fire Protection Acquires A&A Fire Protection
FirstService Corporation announced that its subsidiary Century Fire Protection has acquired A&A Fire Protection, LLC, a South Carolina-based fire sprinkler services provider founded in 1977. The acquisition expands Century's presence in the Carolina markets and strengthens its fire sprinkler and alarm capabilities. A&A's President Jake Gilstrap will continue leading operations with a retained minority equity stake.
CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer
CytoDyn Inc. announced the appointment of Robert E. Hoffman as Chief Executive Officer effective October 20, 2026, replacing Dr. Jacob Lalezari who served in the role since November 2023. Dr. Lalezari will transition to Head of Research and Translational Sciences to focus on identifying new opportunities for leronlimab in solid-tumor oncology. The leadership change comes as CytoDyn prepares for its next phase of clinical development with focus on clinical results, regulatory progress, and strategic partnerships in 2027.
Canadian Investment Regulatory Organization Trade Resumption - GCR
Multiple trading updates on the Canadian Securities Exchange on October 19, 2026: GoldCoast Resource Corp. (GCR) resumes trading at 8:00 AM ET, Altrova Health Inc. (ROVA) resumes at 3:00 PM ET, and Bighorn Metals Corp. (HRNY) remains halted pending undisclosed reasons. Additionally, a securities class action has been filed against Coastal Financial Corporation (CCB) with a December 1, 2026 deadline for investors to join.
Why Berkshire's Latest Move Proves It's Not Really a Warren Buffett Company Anymore
Berkshire Hathaway's $930 million investment in Bending Spoons, a serial software acquirer, marks a significant departure from Warren Buffett's traditional investment philosophy. With Greg Abel now CEO, the company appears willing to take on more tech risk and invest in acquisition-heavy businesses—a strategy Buffett historically criticized. While the position represents only 0.4% of Berkshire's portfolio, analysts suggest it signals a potential shift in the company's investment direction.
Inflation Just Spooked the Market -- But There's Still Good News for Patient Investors
September's inflation report (CPI up 0.6% monthly, 3.7% year-over-year) triggered a market selloff with the S&P 500 falling 1.1% and Nasdaq dropping 1.8%. However, the article argues that long-term investors should remain committed to the market, citing a historical example where a $10,000 S&P 500 index investment made in October 2006 (before the financial crisis) grew to approximately $81,000 by October 2026 with dividend reinvestment, significantly outpacing inflation despite multiple market crashes.
Dario Amodei Predicted at Davos in January 2025 That AI Could Surpass Humans "at Almost Everything" Within Two to Three Years. With Anthropic Now Filing for a $2 Trillion IPO, Is That Timeline Still on Track?
Anthropic has surpassed OpenAI as the leading AI lab, with higher revenue ($16.8B run rate), profitability on an adjusted basis, and an expected IPO in November ahead of OpenAI's delayed 2027 offering. CEO Dario Amodei predicted AI would exceed human capacity by 2027-2028, a timeline that appears on track as Nvidia CEO Jensen Huang claims AGI has already arrived with recent breakthroughs like GPT-6 Astra solving long-standing math and computer science problems.
Real signals or no signal
The system only ranks opportunities when real market and catalyst data is available. Missing data produces a clear unavailable state instead of noise.
Review integrations